DOP54 Identification and development of a 1st in class naturally-derived protein that drives mucosal healing and is orally delivered by an engineered cellular therapy targeting the gastro-intestinal tract

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2022-01, Vol.16 (Supplement_1), p.i102-i102
Main Authors: Shilova, I, La Chat, C, Nigatu, E, Messner, E, Desnoyer, J, Willcoxon, M, Banas, S, Ravichandar, D, Narayan, N, DeSantis, T, Dabbagh, K, Yamamoto, L
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjab232.093